These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 8796815

  • 1. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
    Rapkin AJ, Shoupe D, Reading A, Daneshgar KK, Goldman L, Bohn Y, Brann DW, Mahesh VB.
    J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
    [Abstract] [Full Text] [Related]

  • 2. Transient failure of central opioid tonus and premenstrual symptoms.
    Facchinetti F, Martignoni E, Sola D, Petraglia F, Nappi G, Genazzani AR.
    J Reprod Med; 1988 Jul; 33(7):633-8. PubMed ID: 3050071
    [Abstract] [Full Text] [Related]

  • 3. Effect of naloxone on luteinizing hormone secretion in premenstrual syndrome.
    Chuong CJ, Hsi BP.
    Fertil Steril; 1994 Jun; 61(6):1039-44. PubMed ID: 8194614
    [Abstract] [Full Text] [Related]

  • 4. Differential response to estrogen challenge test in women with and without premenstrual dysphoria.
    Eriksson O, Bäckström T, Stridsberg M, Hammarlund-Udenaes M, Naessén T.
    Psychoneuroendocrinology; 2006 May; 31(4):415-27. PubMed ID: 16359822
    [Abstract] [Full Text] [Related]

  • 5. Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder.
    Nyberg S, Wahlström G, Bäckström T, Sundström Poromaa I.
    Psychoneuroendocrinology; 2004 Jul; 29(6):767-77. PubMed ID: 15110926
    [Abstract] [Full Text] [Related]

  • 6. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.
    Nyberg S, Andersson A, Zingmark E, Wahlström G, Bäckström T, Sundström-Poromaa I.
    Psychoneuroendocrinology; 2005 Oct; 30(9):892-901. PubMed ID: 15979810
    [Abstract] [Full Text] [Related]

  • 7. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
    Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB.
    Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749
    [Abstract] [Full Text] [Related]

  • 8. Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female rhesus monkeys.
    Mello NK, Mendelson JH, Bree MP, Skupny A.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):895-904. PubMed ID: 3133465
    [Abstract] [Full Text] [Related]

  • 9. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
    Hammarbäck S, Damber JE, Bäckström T.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
    [Abstract] [Full Text] [Related]

  • 10. Lack of effect of induced menses on symptoms in women with premenstrual syndrome.
    Schmidt PJ, Nieman LK, Grover GN, Muller KL, Merriam GR, Rubinow DR.
    N Engl J Med; 1991 Apr 25; 324(17):1174-9. PubMed ID: 2011161
    [Abstract] [Full Text] [Related]

  • 11. Lack of plasma norepinephrine cyclicity, increased estradiol during the follicular phase, and of progesterone and gonadotrophins at ovulation in women with premenstrual syndrome.
    Blum I, Lerman M, Misrachi I, Nordenberg Y, Grosskopf I, Weizman A, Levy-Schiff R, Sulkes J, Vered Y.
    Neuropsychobiology; 2004 Apr 25; 50(1):10-5. PubMed ID: 15179014
    [Abstract] [Full Text] [Related]

  • 12. Opioid peptides in pseudocyesis.
    Devane GW, Vera MI, Buhi WC, Kalra PS.
    Obstet Gynecol; 1985 Feb 25; 65(2):183-8. PubMed ID: 3918282
    [Abstract] [Full Text] [Related]

  • 13. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome.
    Cubeddu A, Bucci F, Giannini A, Russo M, Daino D, Russo N, Merlini S, Pluchino N, Valentino V, Casarosa E, Luisi S, Genazzani AR.
    Psychoneuroendocrinology; 2011 May 25; 36(4):523-30. PubMed ID: 20933336
    [Abstract] [Full Text] [Related]

  • 14. The corpus luteum: determinants of progesterone secretion in the normal menstrual cycle.
    Soules MR, Clifton DK, Steiner RA, Cohen NL, Bremner WJ.
    Obstet Gynecol; 1988 May 25; 71(5):659-66. PubMed ID: 3357651
    [Abstract] [Full Text] [Related]

  • 15. Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome.
    Watanabe H, Lau DC, Guyn HL, Wong NL.
    Clin Invest Med; 1997 Aug 25; 20(4):211-23. PubMed ID: 9258576
    [Abstract] [Full Text] [Related]

  • 16. Pulsatile LH secretion in women with premenstrual syndrome (PMS): evidence for normal neuroregulation of the menstrual cycle.
    Reame NE, Marshall JC, Kelch RP.
    Psychoneuroendocrinology; 1992 Aug 25; 17(2-3):205-13. PubMed ID: 1359599
    [Abstract] [Full Text] [Related]

  • 17. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome.
    Seippel L, Bäckström T.
    J Clin Endocrinol Metab; 1998 Jun 25; 83(6):1988-92. PubMed ID: 9626129
    [Abstract] [Full Text] [Related]

  • 18. Regulation of pulsatile secretion of progesterone during the human luteal phase.
    Steele PA, Braund W, Judd SJ.
    Clin Reprod Fertil; 1986 Apr 25; 4(2):117-24. PubMed ID: 3742433
    [Abstract] [Full Text] [Related]

  • 19. Alcohol effects on naloxone-stimulated luteinizing hormone, prolactin and estradiol in women.
    Mendelson JH, Mello NK, Cristofaro P, Ellingboe J, Skupny A, Palmieri SL, Benedikt R, Schiff I.
    J Stud Alcohol; 1987 Jul 25; 48(4):287-94. PubMed ID: 3613578
    [Abstract] [Full Text] [Related]

  • 20. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
    Shoupe D, Montz FJ, Lobo RA.
    J Clin Endocrinol Metab; 1985 Jan 25; 60(1):178-83. PubMed ID: 2981084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.